Cargando…
Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study
(1) Background: Currently, residents ≥ 60 and ≥65 years old in Beijing, China, are eligible for free influenza and pneumococcal polysaccharide vaccines (PPSV23), respectively. The present study aimed to assess the cost-effectiveness of current and alternative strategies of dual influenza and PPSV23...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863432/ https://www.ncbi.nlm.nih.gov/pubmed/36680005 http://dx.doi.org/10.3390/vaccines11010161 |
_version_ | 1784875332984111104 |
---|---|
author | Pi, Zhenfei Aoyagi, Kiyoshi Arima, Kazuhiko Wu, Xiaoliang Ye, Zhaojia Jiang, Yawen |
author_facet | Pi, Zhenfei Aoyagi, Kiyoshi Arima, Kazuhiko Wu, Xiaoliang Ye, Zhaojia Jiang, Yawen |
author_sort | Pi, Zhenfei |
collection | PubMed |
description | (1) Background: Currently, residents ≥ 60 and ≥65 years old in Beijing, China, are eligible for free influenza and pneumococcal polysaccharide vaccines (PPSV23), respectively. The present study aimed to assess the cost-effectiveness of current and alternative strategies of dual influenza and PPSV23 vaccination among the elderly in Beijing. (2) Methods: We developed a Markov state-transition model to compare the costs and the quality-adjusted life years (QALYs) associated with four influenza and PPSV23 vaccination strategies among the elderly in Beijing. The strategies were as follows: (1) no vaccination; (2) only flu vaccine for people ≥ 60 years old; (3) flu vaccine for people ≥ 60 years old and PPSV23 for people ≥ 65 years old; and (4) dual influenza vaccines and PPSV23 for people ≥ 60 years old. Incremental costs and QALYs were quantified to determine the optimal option. If dominant strategies emerged, the Chinese gross domestic product per capita in 2021 (80,976 CNY) was used as the willingness-to-pay (WTP) threshold to covert QALYs into the monetary equivalent. (3) Results: The current program saved costs and increased QALYs compared to no vaccination or flu vaccine-only strategies. However, extending free PPSV23 to people ≥ 60 years old saved 0.35 CNY additionally while increasing QALYs marginally compared with the current policy. Results were robust in all sensitivity analyses. (4) Conclusion: Beijing’s current dual influenza and pneumococcal vaccination program was cost-effective among the elderly compared with the preceding policies of no vaccination and flu-only immunization programs. However, the program can further save money while enhancing the population health by extending PPSV23 to all people ≥ 60 years old. |
format | Online Article Text |
id | pubmed-9863432 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98634322023-01-22 Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study Pi, Zhenfei Aoyagi, Kiyoshi Arima, Kazuhiko Wu, Xiaoliang Ye, Zhaojia Jiang, Yawen Vaccines (Basel) Article (1) Background: Currently, residents ≥ 60 and ≥65 years old in Beijing, China, are eligible for free influenza and pneumococcal polysaccharide vaccines (PPSV23), respectively. The present study aimed to assess the cost-effectiveness of current and alternative strategies of dual influenza and PPSV23 vaccination among the elderly in Beijing. (2) Methods: We developed a Markov state-transition model to compare the costs and the quality-adjusted life years (QALYs) associated with four influenza and PPSV23 vaccination strategies among the elderly in Beijing. The strategies were as follows: (1) no vaccination; (2) only flu vaccine for people ≥ 60 years old; (3) flu vaccine for people ≥ 60 years old and PPSV23 for people ≥ 65 years old; and (4) dual influenza vaccines and PPSV23 for people ≥ 60 years old. Incremental costs and QALYs were quantified to determine the optimal option. If dominant strategies emerged, the Chinese gross domestic product per capita in 2021 (80,976 CNY) was used as the willingness-to-pay (WTP) threshold to covert QALYs into the monetary equivalent. (3) Results: The current program saved costs and increased QALYs compared to no vaccination or flu vaccine-only strategies. However, extending free PPSV23 to people ≥ 60 years old saved 0.35 CNY additionally while increasing QALYs marginally compared with the current policy. Results were robust in all sensitivity analyses. (4) Conclusion: Beijing’s current dual influenza and pneumococcal vaccination program was cost-effective among the elderly compared with the preceding policies of no vaccination and flu-only immunization programs. However, the program can further save money while enhancing the population health by extending PPSV23 to all people ≥ 60 years old. MDPI 2023-01-11 /pmc/articles/PMC9863432/ /pubmed/36680005 http://dx.doi.org/10.3390/vaccines11010161 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pi, Zhenfei Aoyagi, Kiyoshi Arima, Kazuhiko Wu, Xiaoliang Ye, Zhaojia Jiang, Yawen Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study |
title | Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study |
title_full | Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study |
title_fullStr | Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study |
title_full_unstemmed | Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study |
title_short | Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study |
title_sort | optimization of elderly influenza and pneumococcal immunization programs in beijing, china using health economic evaluations: a modeling study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863432/ https://www.ncbi.nlm.nih.gov/pubmed/36680005 http://dx.doi.org/10.3390/vaccines11010161 |
work_keys_str_mv | AT pizhenfei optimizationofelderlyinfluenzaandpneumococcalimmunizationprogramsinbeijingchinausinghealtheconomicevaluationsamodelingstudy AT aoyagikiyoshi optimizationofelderlyinfluenzaandpneumococcalimmunizationprogramsinbeijingchinausinghealtheconomicevaluationsamodelingstudy AT arimakazuhiko optimizationofelderlyinfluenzaandpneumococcalimmunizationprogramsinbeijingchinausinghealtheconomicevaluationsamodelingstudy AT wuxiaoliang optimizationofelderlyinfluenzaandpneumococcalimmunizationprogramsinbeijingchinausinghealtheconomicevaluationsamodelingstudy AT yezhaojia optimizationofelderlyinfluenzaandpneumococcalimmunizationprogramsinbeijingchinausinghealtheconomicevaluationsamodelingstudy AT jiangyawen optimizationofelderlyinfluenzaandpneumococcalimmunizationprogramsinbeijingchinausinghealtheconomicevaluationsamodelingstudy |